COOL — Core One Labs Income Statement
0.000.00%
HealthcareSpeculativeMicro Cap
Annual income statement for Core One Labs, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 15 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4.08 | 0 | 0 | 0.432 | 0.573 |
Cost of Revenue | |||||
Gross Profit | -1.69 | — | — | — | — |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 16 | 11.6 | 43 | 38.1 | 20.7 |
Operating Profit | -11.9 | -11.6 | -43 | -37.6 | -20.1 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -13.2 | -10.7 | -46.9 | -37.1 | -20 |
Net Income After Taxes | -13.2 | -10.7 | -46.9 | -37.1 | -20 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -12.3 | -21.5 | -54.6 | -37.1 | -20 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -12.3 | -21.5 | -54.6 | -37.1 | -20 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -10.6 | -6.06 | -1.82 | -0.944 | -0.257 |
Dividends per Share |